Ju Yang

Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer

D. Gomez, Z. Liao, S. Hahn, 2017, Oncotarget.

Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC).

Xianglin Yuan, H. Qiu, G. Hu, 2013, Cancer epidemiology.

Combined effects of leukocyte telomere length, p53 polymorphism and human papillomavirus infection on esophageal squamous cell carcinoma in a Han Chinese population.

Xianglin Yuan, H. Qiu, G. Hu, 2014, Cancer epidemiology.

Genetic variants in PI3K/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapy

Jing Li, Shiying Yu, Xianglin Yuan, 2015, Cancer medicine.

Radiation Dose, Local Disease Progression, and Overall Survival in Patients With Inoperable Non-Small Cell Lung Cancer After Concurrent Chemoradiation Therapy.

D. Gomez, Y. Liu, R. Komaki, 2018, International journal of radiation oncology, biology, physics.

Cardiac atlas development and validation for automatic segmentation of cardiac substructures.

Tinsu Pan, Zhongxing Liao, Jinzhong Yang, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Associations between Single-Nucleotide Polymorphisms in the PI3K–PTEN–AKT–mTOR Pathway and Increased Risk of Brain Metastasis in Patients with Non–Small Cell Lung Cancer

Z. Liao, J. Zhao, Xianglin Yuan, 2013, Clinical Cancer Research.

TGFβ1 Polymorphisms Predict Distant Metastasis–Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy

Q. Wei, R. Komaki, Z. Liao, 2013, PloS one.

Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non‐small cell lung cancer

D. Gomez, R. Komaki, Z. Liao, 2018, Cancer medicine.

The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy

D. Gomez, Z. Liao, L. Levy, 2017, Translational oncology.

Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non – Small Cell Lung Cancer ( NSCLC ) Receiving

Z. Liao, L. Levy, Yipeng Song, 2017 .